Detection of gonadotropin-releasing hormone receptor and its mRNA in primary human epithelial ovarian cancers

International Journal of Gynecological Cancer

Volumn 14, Issue 3, 2004, Pages 451-458

  Chien, C H ^a   Chen, C H ^b   Lee, C Y G ^c   Chang, T C ^b   Chen, R J ^b   Chow, Song Nan ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Immunohistochemistry; Ovarian cancer; RGnRH; RGnRH mRNA; RT PCR; Western blot

Indexed keywords

BIOTIN; GONADORELIN RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; NEUROPEPTIDE; STREPTAVIDIN;

ARTICLE; AUTOCRINE EFFECT; CANCER PATIENT; CHEMOLUMINESCENCE; EPITHELIUM TUMOR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; TUMOR GROWTH; WESTERN BLOTTING;

BLOTTING, WESTERN; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RECEPTORS, LHRH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 2942585424     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891x.2004.014304.x     Document Type: Article

References (43)

1. Bramley TA, McPhie CA, Menzies GS. Human placental gonadotrophin-releasing hormone (GnRH) binding sites: characterization, properties and ligand specificity. Placenta 1992;13:555-81.
2. Eidne KA, Flanagan CA, Millar RP. Gonadotropin-releasing hormone binding sites in human breast carcinoma. Science 1985;229:989-91.
3. Emons G, Ortmann O, Becker M et al. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Res 1993;53:5439-46.
4. Srkalovic G, Wittliff JL, Schally AV. Detection and partial characterization of receptors for [D-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma. Cancer Res 1990;50:1841-6.
5. Khodr GS, Siler-Khodr TM. Placental luteinizing hormone-releasing factor and its synthesis. Science 1980;207:315-7.
6. Harris N, Dutlow C, Eidne K, Dong KW, Roberts J, Millar R. Gonadotropin-releasing hormone gene expression in MDA-MB-231 and ZR-75-1 breast carcinoma cell lines. Cancer Res 1991;51:2577-81.
7. Irmer G, Burger C, Ortmann O, Schulz KD, Emons G. Expression of luteinizing hormone releasing hormone and its mRNA in human endometrial cancer cell lines. J Clin Endocrinol Metab 1994;79:916-9.
8. Emons G, Schroder B, Ortmann O, Westphalen S, Schulz KD, Schally AV. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines. J Clin Endocrinol Metab 1993;77:1458-64.
9. Eidne KA, Flanagan CA, Harris NS, Millar RP. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists. J Clin Endocrinol Metab 1987;64:425
10. Gallagher CJ, Oliver RT, Oram DH et al. A new treatment for endometrial cancer with gonadotrophin releasinghormone analogue. Br J Obstet Gynaecol 1991;98:1037-41.
11. Kleinman D, Roberts CT Jr, LeRoith D, Schally AV, Levy J, Sharoni Y. Regulation of endometrial cancer cell growth by insulin-like growth factors and the luteinizing hormone-releasing hormone antagonist SB-75. Regul Pept 1993;48:91-8.
12. Jeyarajah AR, Gallagher CJ, Blake PR et al. Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer. Gynecol Oncol 1996;63:47-52.
13. Shibata S, Sato H, Ota H, Karube A, Takahashi O, Tanaka T. Involvement of annexin V in antiproliferafive effects of gonadotropin-releasing hormone agonists on human endometrial cancer cell line. Gynecol Oncol 1997,66:217-21.
14. Thompson MA, Adelson MD, Kaufman LM. Lupron retards proliferation of ovarian epithelial tumor cells cultured in serum-free medium. J Clin Endocrinol Metab 1991;72:1036-41.
15. Medl M, Peters-Engel C, Fuchs G, Leodolter S. Triptorelin (D-Trp-6-LHRH) in combination with carboplatincontaining polychemotherapy for advanced ovarian cancer: a pilot study. Anticancer Res 1993;13:2373-6.
16. Connor JP, Buller RE, Conn PM. Effects of GnRH analogs on six ovarian cancer cell lines in culture. Gynecol Oncol 1994;54:80-6.
17. Peterson CM, Jolles CJ, Carrell DT et al. GnRH agonist therapy in human ovarian epithelial carcinoma (OVCAR-3) heterotransplanted in the nude mouse is characterized by latency and transience. Gynecol Oncol 1994;52:26-30.
18. van der Vange N, Greggi S, Burger CW, Kenemans P, Vermorken JB. Experience with hormonal therapy in advanced epithelial ovarian cancer. Acta Oncol 1995;34:813-20.
19. Falkson CI, Falkson HC, Falkson G. Cisplatin versus cisplatin plus DpTrp-6pLHRH in the treatment of ovarian cancer: a pilot trial to investigate the effect of the addition of a GnRH analogue to cisplatin. Oncology 1996;53:313-7.
20. Motomura S. Induction of apoptosis in ovarian carcinoma cell line by gonadotropin-releasing hormone agonist. Kurume Med J 1998;45:27-32.
21. Kakar SS, Musgrove LC, Devor DC, Sellers JC, Neill JD. Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem Biophys Res Commun 1992;189:289-95.
22. Kakar SS, Grantham K, Musgrove LC, Devor D, Sellers JC, Neill JD. Rat gonadotropin-releasing hormone (GnRH) receptor: tissue expression and hormonal regulation of its mRNA. Mol Cell Endocrinol 1994;101:151-7.
23. Perrin MH, Bilezikjian LM, Hoeger C et al. Molecular and functional characterization of GnRH receptors cloned from rat pituitary and a mouse pituitary tumor cell line. Biochem Biophys Res Commun 1993;191:1139-44.
24. Sealfon SC, Millar RP. Functional domains of the gonadotropin-releasing hormone receptor. Cell Mol Neurobiol 1995;15:25-42.
25. Ohno T, Imai A, Furui T, Takahashi K, Tamaya T. Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma. Am J Obstet Gynecol 1993;169:605-10.
26. Dong KW, Yu KL, Roberts JL. Identification of a major up-stream transcription start site for the human progonadotropin-releasing hormone gene used in reproductive tissues and cell lines. Mol Endocrinol 1993;7:1654-66.
27. Hazum E, Schvartz I, Popliker M. Production and characterization of antibodies to gonadotropin-releasing hormone receptor. J Biol Chem 1987;262:531-4.
28. Karande AA, Rajeshwari K, Schol DJ, Hilgers JH. Establishment of immunological probes to study human gonadotropin-releasing hormone receptors. Mol Cell Endocrinol 1995;30:51-6.
29. Lee CY, Ho J, Chow SN, Yasojima K, Schwab C, McGeer PL. Immunoidentification of gonadotropin releasing hormone receptor in human sperm, pituitary and cancer cells. Am J Reprod Immunol 2000;44:170-7.
30. Murdoch WJ. Immunolocalization of a gonadotropin-releasing hormone receptor site in murine endometrium that mediates apoptosis. Cell Tissue Res 1995;282:527-9.
31. Yasojima K, Schwab C, McGeer EG, McGeer PL. Human heart generates complement proteins that are upregulated and activated after myocardial infarction. Circ Res 1998;19:860-9.
32. Millar R, Conklin D, Lofton-Day C et al. A novel human GnRH receptor homolog gene: abundant and wide tissue distribution of the antisense transcript. J Endocrinol 1999;162:117-26.
33. Clayton RN. Gonadotropin-releasing hormone: its actions and receptors. J Endocrinol 1989;120:11-9.
34. Pahwa GS, Vollmer G, Knuppen R, Emons G. Photoaffinity labelling of gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata. Biochem Biophys Res Commun 1989;161:1086-92.
35. 2+ in human syncytiotrophoblast cells increased by gonadotropin-releasing hormone. Endocrinology 1993;133:2220-6.
36. Peng C, Fan NC, Ligier M, Vaananen J, Leung PC. Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells. Endocrinology 1994;135:1740-6.
37. Wiznitzer A, Marbach M, Hazum E, Insler V, Sharoni Y, Levy J. Gonadotropin-releasing hormone specific binding site in uterine leiomyoma. Biochem Biophys Res Commun 1988;152:1326-31.
38. Grundker C, Schulz K, Gunthert AR, Emons G. Luteinizing hormone-releasing hormone induces nuclear factor kappa-B-activation and inhibits apoptosis in ovarian cancer cells. J Clin Endocrinol Metab 2000;85:3815-20.
39. Emons G, Weiss S, Ortmann O, Grundker C, Schulz KD. LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer. Eur J Endocrinol 2000;142:665-70.
40. Furui T, Imai A, Tamaya T. Intratumoral level of gonadotropin-releasing hormone in ovarian and endometrial cancers. Oncol Rep 2002;9:349-52.
41. Chen A, Kaganovsky E, Rahimipour S, Ben-Aroya N, Okon E, Koch Y. Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by downregulation of acidic ribosomal phosphoproteins P1 and P2. Cancer Res 2002;15:1036-44.
42. Grunker C, Gunthert AR, Millar RP, Emons G. Expression of gonadotropin-releasing hormone ? (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab 2002;87:1427-30.
43. Grundker C, Volker P, Emons G. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G-protein alpha α-mediated activation of phosphotyrosine phosphatase. Endocrinology 2001;142:2369-80.